Delivery Order SPE2DB24D8003-SPE2DB24FJTLJ

Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $11,449.26 firm fixed-price delivery order is for the supply of pharmaceutical products, specifically LO LOESTRIN FE 1-10 tablets, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $6,534.54, is for the delivery of pharmaceutical products, specifically the drug LO LOESTRIN FE 1-10 TABLET 28S. The contract is a Firm Fixed Price (FFP) type and is not a set-aside. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00,...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBRBT, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc. The $1,643.04 delivery order contract is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. Dakota Drug, Inc. is a self-certified small disadvantaged business registered in SAM.gov, operating as a for-profit Subchapter S corporation. The company specializes in providing pharmaceutical products,...
This is a firm fixed-price delivery order contract awarded by the U.S. Department of Defense's Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has a period of performance through June 17, 2024 and a ceiling value of $3,175.83. The contract is for the delivery of LO LOESTRIN FE 1-10 TABLET 28S, which are pharmaceutical products used for medical purposes. This award is part of a larger Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $2,656.79, is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. This award does not have a set-aside designation. The contract supports the DLA Troop Support Medical's mission of providing comprehensive...
This federal contract award, valued at $3,960.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the pharmaceutical product "LO LOESTRIN FE 1-10 TABLET 28S" with an ultimate completion date of January 22, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the branded contraceptive medication Lo Loestrin Fe. The $1,724.62 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that enables the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,332.40, is a delivery order contract for the supply of Lo Loestrin Fe 1-10 tablet 28S, a prescription medication. The contract has an ultimate completion date of March 27, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,064.98 firm-fixed-price delivery order contract is for the supply of the medication Lo Loestrin Fe 1-10 Tablet 28s. The contract has an ultimate completion date of January 31, 2023 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,479.21 firm fixed-price delivery order is for the medication Lo Loestrin Fe 1-10 Tablet 28S, with an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which...
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB24FJTLJ
    Delivery Order

This federal contract award, with ID SPE2DB24D8003|SPE2DB24FJTLJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc. The $2,360.74 firm fixed-price delivery order is for the pharmaceutical product Lo Loestrin FE 1-10 Tablet 28s. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, primarily the Department of Defense.

This award is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This single-award IDC allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations under the DLA Troop Support Medical's ECAT Generation V Program. The contract does not have a set-aside designation.

Generated 11/27/24, 9:36 AM